These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35942483)

  • 1. COVID-19's impacts on business activities and female workers: Empirical evidence from global developing economies.
    Wu R
    J Int Dev; 2022 Jul; ():. PubMed ID: 35942483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiscal Stimulus and Firms' Sales and Capital Expenditure During the Global Financial Crisis.
    Correa-Caro C; Medina L; Poplawski-Ribeiro M; Sutton B
    Comp Econ Stud; 2021; 63(3):489-535. PubMed ID: 34366561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-speed rail and firms' environmental performance: empirical evidence from China.
    Wang Z; Huang W; Li K; Wei W; Liu Z
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):55187-55199. PubMed ID: 36884167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is ESG the key to unlock debt financing during the COVID-19 pandemic? International evidence.
    Srivastava J; Sampath A; Gopalakrishnan B
    Financ Res Lett; 2022 Oct; 49():103125. PubMed ID: 35859705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Firms' solidity before an exogenous shock: Covid-19 pandemic in Italy.
    Costa S; Sallusti F; Vicarelli C; Zurlo D
    Econ Anal Policy; 2022 Dec; 76():946-961. PubMed ID: 36277035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to promote technology adoption in firms: A systematic review.
    Alfaro-Serrano D; Balantrapu T; Chaurey R; Goicoechea A; Verhoogen E
    Campbell Syst Rev; 2021 Dec; 17(4):e1181. PubMed ID: 36950339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of corporate digital transformation on firms' performance in utilities sector.
    Wang D; Xia X
    Heliyon; 2024 Jan; 10(1):e23362. PubMed ID: 38169836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Business-community relations under COVID-19: A study of micro and small firms.
    Bressan A; Duarte Alonso A; Thi Kim Vu O
    J Bus Res; 2023 Jan; 155():113441. PubMed ID: 36408442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Productivity and firm exit during the COVID-19 crisis: cross-country evidence.
    Muzi S; Jolevski F; Ueda K; Viganola D
    Small Bus Econ (Dordr); 2023; 60(4):1719-1760. PubMed ID: 38625239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Firm innovation activities and consumer brand loyalty: A path to business sustainability in Asia.
    Yi L; Khan MS; Safeer AA
    Front Psychol; 2022; 13():942048. PubMed ID: 35959050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Women-Led Businesses around the World.
    Liu Y; Wei S; Xu J
    Financ Res Lett; 2021 Nov; 43():102012. PubMed ID: 34803532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does economic policy uncertainty impact firms' capital structure policy? Evidence from Western European economies.
    Athari SA; Bahreini M
    Environ Sci Pollut Res Int; 2023 Mar; 30(13):37157-37173. PubMed ID: 36571690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general equilibrium assessment of COVID-19's labor productivity impacts on china's regional economies.
    He X; Balistreri EJ; Kim GH; Zhang W
    J Product Anal; 2022; 58(2-3):129-150. PubMed ID: 35910675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can artificial intelligence boost firms' exports? evidence from China.
    Zhang Z; Deng F
    PLoS One; 2023; 18(8):e0283230. PubMed ID: 37611039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of Covid-19 on Norwegian salmon exports: A firm-level analysis.
    Straume HM; Asche F; Oglend A; Abrahamsen EB; Birkenbach AM; Langguth J; Lanquepin G; Roll KH
    Aquaculture; 2022 Dec; 561():738678. PubMed ID: 35937035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.